GlobeNewswire

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
03/03/2026
MINNEAPOLIS, March 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Prolium Bioscience Launches with $50 Million and Announces First Patients Dosed with PRO-203, a Potential Best-in-Class CD20xCD3 T-Cell Engager, for Severe Autoimmune Disease
03/03/2026
Initial $50M Series A investment from founding investor RTW Investments Proceeds will fund clinical development of PRO-203 in systemic sclerosis (SSc) and multiple additional severe autoimmune diseases NEW YORK, March [...]
Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
03/03/2026
Randomized, placebo-controlled study to evaluate safety, tolerability, and potential for positive impact on lung function AUSTIN, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a [...]
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
03/03/2026
NEW HOPE, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through [...]
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
03/03/2026
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a [...]
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
03/03/2026
Phase 1a/1b, first-in-human study to evaluate safety and tolerability for investigational ARQ-234 in healthy volunteers and adults with moderate to severe atopic dermatitis ARQ-234 is a potent fusion-protein agonist of [...]
Opus Genetics to Present at Upcoming Investor Conferences in March 2026
03/03/2026
RESEARCH TRIANGLE PARK, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc . (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion
03/03/2026
ATHENS, Ga., March 03, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP) (“Company”), a pioneer in eco-friendly biosafety and health solutions, announces a significant strengthening of its e-commerce [...]
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
03/03/2026
-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 in CGD; plan to [...]
Fort Wayne Rheumatologists Monica Reddy, Karen Ringwald and Anil Rao Open Fort Wayne Rheumatology and Infusion
03/03/2026
FORT WAYNE, Ind., March 03, 2026 (GLOBE NEWSWIRE) -- Fort Wayne Rheumatology and Infusion is now open and serving patients at 7910 W. Jefferson Blvd., Suite 217, in Fort Wayne. The new practice is led by Board-certified [...]
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
03/03/2026
EMERYVILLE, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today [...]
Inteleos 2026 Leadership Elections Accelerate Vision for Global Healthcare
03/03/2026
New leadership across the Board and Councils align with the organization’s fifty-year legacy and strategic policy ROCKVILLE, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Inteleos today announced its 2026 leadership elections [...]
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial
03/03/2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet [...]
Tekton Research Appoints Dr. Jara McDonald as Executive Medical Director to Support Continued Growth in Cardiometabolic Research
03/03/2026
Double Board-Certified Obesity, Diabetes & Integrative Medicine Specialist to Lead Medical Strategy, Sponsor Engagement, and Industry Collaboration AUSTIN, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Tekton Research, [...]
Human Appeal hosts global Grand Iftars, providing over 250,000 meals for vulnerable people this Ramadan
03/03/2026
Humanitarian charity running large scale Iftars for displaced peoples across Palestine, Iraq, Pakistan, Somalia, Sudan, Syria and Yemen MANCHESTER, United Kingdom, March 03, 2026 (GLOBE NEWSWIRE) -- Leading global [...]
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
03/03/2026
VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to provide more effective and durable treatment than the current standard of care for patients with wet AMD, DME and RVO [...]
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference
03/03/2026
SOUTH SAN FRANCISCO, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
03/03/2026
HINGHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that the Company, both in the [...]
PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology Workflow
03/03/2026
BOSTON, March 03, 2026 (GLOBE NEWSWIRE) -- PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum